Free Trial

PROCEPT BioRobotics (PRCT) Competitors

PROCEPT BioRobotics logo
$39.54 +1.08 (+2.80%)
As of 11:06 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PRCT vs. STVN, IRTC, BLCO, GKOS, TMDX, NVST, LIVN, SLNO, WRBY, and INSP

Should you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

PROCEPT BioRobotics vs. Its Competitors

PROCEPT BioRobotics (NASDAQ:PRCT) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Stevanato Group has a net margin of 11.73% compared to PROCEPT BioRobotics' net margin of -30.60%. Stevanato Group's return on equity of 10.34% beat PROCEPT BioRobotics' return on equity.

Company Net Margins Return on Equity Return on Assets
PROCEPT BioRobotics-30.60% -23.73% -17.34%
Stevanato Group 11.73%10.34%6.21%

Stevanato Group has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PROCEPT BioRobotics$224.50M9.80-$91.41M-$1.55-25.51
Stevanato Group€1.19B6.89€127.45M€0.5450.37

PROCEPT BioRobotics has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500.

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 17.4% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, PROCEPT BioRobotics had 4 more articles in the media than Stevanato Group. MarketBeat recorded 7 mentions for PROCEPT BioRobotics and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.76 beat PROCEPT BioRobotics' score of 0.58 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PROCEPT BioRobotics
2 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PROCEPT BioRobotics presently has a consensus target price of $70.00, suggesting a potential upside of 77.05%. Given PROCEPT BioRobotics' higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PROCEPT BioRobotics
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.83

Summary

Stevanato Group beats PROCEPT BioRobotics on 10 of the 17 factors compared between the two stocks.

Get PROCEPT BioRobotics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRCT vs. The Competition

MetricPROCEPT BioRoboticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.21B$6.73B$5.77B$10.50B
Dividend YieldN/A1.21%5.61%4.58%
P/E Ratio-25.6226.6076.9527.03
Price / Sales9.80197.43553.80128.22
Price / CashN/A22.1425.8131.15
Price / Book5.135.1213.886.54
Net Income-$91.41M$178.07M$3.30B$271.76M
7 Day Performance-0.09%2.81%2.46%3.85%
1 Month Performance-4.11%7.82%4.90%8.34%
1 Year Performance-50.72%21.96%83.63%27.26%

PROCEPT BioRobotics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRCT
PROCEPT BioRobotics
2.7792 of 5 stars
$39.54
+2.8%
$70.00
+77.1%
-54.7%$2.21B$224.50M-25.62430Positive News
STVN
Stevanato Group
N/A€26.21
-0.8%
N/A+40.2%€7.94B€1.19B48.545,521Positive News
IRTC
iRhythm Technologies
1.1583 of 5 stars
$176.16
-2.0%
$163.82
-7.0%
+163.9%$5.78B$657.23M-60.122,000Positive News
Analyst Forecast
BLCO
Bausch + Lomb
1.8767 of 5 stars
$15.23
+0.2%
$15.56
+2.2%
-23.5%$5.38B$4.79B-19.5213,500
GKOS
Glaukos
4.7084 of 5 stars
$80.72
-2.5%
$124.83
+54.6%
-33.7%$4.75B$383.48M-48.92780Positive News
Analyst Forecast
TMDX
TransMedics Group
2.0774 of 5 stars
$114.29
-0.2%
$122.11
+6.8%
-24.2%$3.91B$441.54M59.22210
NVST
Envista
3.7742 of 5 stars
$21.12
+0.5%
$20.92
-0.9%
+10.0%$3.49B$2.51B65.9912,300
LIVN
LivaNova
2.7777 of 5 stars
$55.43
-1.4%
$59.71
+7.7%
+8.6%$3.07B$1.25B-14.252,900Positive News
SLNO
Soleno Therapeutics
4.4497 of 5 stars
$51.17
-4.6%
$115.09
+124.9%
+9.6%$2.85BN/A-12.3630
WRBY
Warby Parker
1.457 of 5 stars
$26.37
-1.4%
$24.06
-8.8%
+100.2%$2.81B$771.32M-376.723,780
INSP
Inspire Medical Systems
4.8819 of 5 stars
$80.90
+1.1%
$164.50
+103.3%
-62.9%$2.37B$802.80M46.761,246Analyst Downgrade

Related Companies and Tools


This page (NASDAQ:PRCT) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners